HopeStage
Back to all studies
CompletedNCT02562430

Brain Processes Involved in Placebo Response in Depression

About this titleRead the official source — NCT02562430

Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.

Medication studyAges 18–60United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2016
Recruitment status
Completed
Enrollment listed in the registry
76
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT02562430
Official title
Show the full official title

Neurobiological Underpinnings of Placebo Response in Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Welbutrin XL and placebo to find out how the approaches affected depression symptoms in people with depression.

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Welbutrin XL and Placebo.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies